Drug Discovery Firms and Business Alliances for Sustainable Innovation

Drug Discovery Firms and Business Alliances for Sustainable Innovation

Biotech startup firms developing pharmaceutical seeds from scientific and technological innovation are burdened by significant Research & Development (R&D) expenses, long-term R&D operations, and low probability of R&D success. To address these challenges while sustainably creating i...

Full description

Bibliographic Details
Main Authors: Yoshimi Harada, Huayi Wang, Kota Kodama, Shintaro Sengoku
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Sustainability
Subjects:
biotechnology
startup
business alliance
drug discovery
research and development
risk management
Online Access:https://www.mdpi.com/2071-1050/13/7/3599

Internet

https://www.mdpi.com/2071-1050/13/7/3599

Similar Items